Supernus Pharmaceuticals Excess Tax Benefit from Stock Compensation (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

49.82 -0.18 (-0.36%) USD | NASDAQ | Jan 20, 16:00

49.80 -0.02 (-0.04%) After-Hours: 20:00

View Excess Tax Benefit from Stock Compensation (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Excess Tax Benefit from Stock Compensation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

Start Trial

Amphastar Pharmaceuticals, Inc.	--
BridgeBio Pharma, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Assembly Biosciences, Inc.	--
Viking Therapeutics, Inc.	--